The Gastrointestinal Cancer Channel is supported with funding from Gilead Sciences (Silver) and Revolution Medicines (Silver).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ASCO 2023 | Challenges in advanced GIST: tackling resistance to therapies
Robin Jones, MBBS, MRCP, MD, The Royal Marsden Hospital, London, UK, discusses challenges in the current management of advanced gastrointestinal stromal tumors, such as the development of resistance stemming from the heterogeneity of this disease. This may be tackled by the use of combination therapies, as well as novel agents in earlier stages of disease. This interview took place at the American Society of Clinical Oncology (ASCO) 2023 Annual Congress in Chicago, IL.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
